ATNX Insider Trading Activity and SEC Form 4 Filings
ATNX insider trading summary
No open-market insider purchases or sales of Athenex, Inc. (ATNX) have been reported on SEC Form 4 in the past 12 months.
Latest ATNX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 22, 2022 | Jinn Wu | Director | Buy | $4K (10,000 @ $0.42) |
| Aug 19, 2022 | Johnson Yiu Nam Lau | CEO and Chairman of the Board | Buy | $9K (20,000 @ $0.45) |
| Nov 22, 2021 | Johnson Yiu Nam Lau | CEO and Chairman of the Board | Buy | $6K (3,000 @ $1.84) |
| Nov 18, 2021 | Johnson Yiu Nam Lau | CEO and Chairman of the Board | Buy | $6K (3,000 @ $1.87) |
| Nov 17, 2021 | Jordan Kanfer | Director | Buy | $10K (4,952 @ $2.02) |
| Nov 17, 2021 | Jinn Wu | Director | Buy | $40K (20,000 @ $2.02) |
| Nov 17, 2021 | Jinn Wu | Director | Buy | $21K (10,000 @ $2.05) |
| Nov 16, 2021 | Johnson Yiu Nam Lau | CEO and Chairman of the Board | Buy | $6K (3,000 @ $2.06) |
| Nov 16, 2021 | Rudolf Kwan | EVP, Chief Medical Officer | Buy | $8K (4,000 @ $2.05) |
| Nov 15, 2021 | Johnson Yiu Nam Lau | CEO and Chairman of the Board | Buy | $11K (5,000 @ $2.12) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.